Dr. Blander completed her doctoral research training at the University of Pittsburgh where she examined immune recognition of the tumor antigen MUC-1 under the mentorship of Dr. Olivera Finn and supported by a Women in Science Program Award from the U.S. Department of Education’s Graduate Assistance in Areas of National Need. She undertook a post-doctoral fellowship training at Yale University with Drs. Charles Janeway and Ruslan Medzhitov where she studied T cell differentiation and Toll-like receptor dependent regulation of phagocytosis and antigen presentation. Dr. Blander joined the Faculty at the Icahn School of Medicine at Mount Sinai in 2006, and became an Associate Professor in 2011.
Dr. Blander moved to Cornell University in November 2016 and became a Professor of Immunology at the Jill Roberts Institute for IBD Research at Weill Cornell Medicine, Cornell University in New York City. Dr. Blander has developed an Innate Immunity Research Program centered around the function of macrophages and dendritic cells in various settings of infection, cell death, autoimmunity, and cancer. A comparison of how phagocytes tailor their responses to apoptotic cell and microbial cargo has allowed her laboratory to make major strides in understanding the nuances of the differential immune response in the context of enteric infection, intestinal homeostasis, and malignant transformation. Dr. Blander is funded by the National Institutes of Health, the Leukemia and Lymphoma Society, and the Burroughs Wellcome Fund. She has been named Searle Scholar, American Cancer Society Research Scholar, J. V. Satterfield Arthritis Investigator, Irma T. Hirschl and Monique Weill-Caulier Scholar, and winner of the 2009 G. Jeanette Thorbecke award. She has received the Icahn School of Medicine Junior Faculty Award for Academic Excellence and the Harold and Golden Lamport Basic Research Award.